Validea Benjamin Graham Strategy Daily Upgrade Report

Validea's Value Investor model, based on Benjamin Graham's deep value strategy, upgraded Utah Medical Products Inc. (UTMD) from a 71% to an 86% rating due to the firm’s underlying fundamentals and stock valuation; a score above 80% indicates the strategy has some interest in the stock. The upgrade reflects UTMD's strong performance in key Graham criteria, including low P/E and P/B ratios, low debt, and solid long-term earnings growth, though the company failed the sales test.

Analysis

Utah Medical Products Inc. (UTMD), a small-cap value stock operating in the Medical Equipment & Supplies industry, has seen its rating significantly upgraded from 71% to 86% by Validea's Value Investor model, which is predicated on Benjamin Graham's deep value investment strategy. This elevation above the 80% threshold signifies a notable interest from the model, driven by the company's underlying fundamentals and current stock valuation. UTMD successfully meets several key Graham criteria, including a low Price-to-Earnings (P/E) ratio, a low Price-to-Book (P/B) ratio, a strong current ratio, low long-term debt in relation to net current assets, and solid long-term Earnings Per Share (EPS) growth. Despite these strengths, the company failed to meet the model's 'SALES' criterion. Utah Medical Products specializes in the development, manufacture, and marketing of disposable and reusable specialty medical devices, with a particular focus on healthcare for women and their babies, encompassing products for critical care, labor and delivery, and urology.

Key Decisions for Investors

• Investors employing a Benjamin Graham-style value investing approach may find UTMD increasingly compelling due to its improved 86% rating, which highlights favorable valuation and fundamental characteristics.
• A key area for further investigation is the company's sales performance, as its failure to pass the 'SALES' test within the Graham model suggests potential top-line growth challenges despite other financial strengths.
• Consideration should be given to UTMD's ability to leverage its specialized niche in women's and babies' healthcare to improve sales figures, as this could unlock further value if revenue growth aligns with its otherwise strong fundamental profile.